-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Orchestra BioMed Holdings, Inc. quarterly/annual Depreciation history and growth rate from 2022 to 2023.
- Orchestra BioMed Holdings, Inc. Depreciation for the quarter ending September 30, 2024 was $76K, a 7.04% increase year-over-year.
- Orchestra BioMed Holdings, Inc. Depreciation for the twelve months ending September 30, 2024 was $297K, a 4.21% increase year-over-year.
- Orchestra BioMed Holdings, Inc. annual Depreciation for 2023 was $287K, a 29.3% increase from 2022.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)